Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

November 20, 2016

Study Completion Date

December 31, 2016

Conditions
Psoriasis
Interventions
DRUG

IDP-118 Lotion

Lotion

DRUG

Tazorac Cream

Cream

DRUG

IDP-118 Vehicle Lotion

Lotion

DRUG

IDP-118 Vehicle Cream

Cream

Trial Locations (14)

22901

Valeant Site 02, Charlottesville

29601

Valeant Site 10, Greenville

32065

Valeant Site 13, Orange Park

33601

Valeant Site 01, Tampa

Valeant Site 04, Tampa

33780

Valeant Site 11, Pinellas Park

37129

Valeant Site 03, Murfreesboro

46168

Valeant Site 05, Plainfield

48346

Valeant Site 09, Clarkston

55421

Valeant Site 07, Fridley

64501

Valeant Site 14, Saint Joseph

77598

Valeant Site 08, Webster

77840

Valeant Site 06, College Station

91316

Valeant Site 12, Encino

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT02785159 - Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis | Biotech Hunter | Biotech Hunter